Methylene Blue Purification via Redox Recrystallization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for purifying methylene blue are inefficient in removing metal and organic contaminants, particularly Azure compounds, which are problematic for pharmaceutical-grade production due to their structural similarity to methylene blue, making it difficult to achieve the required purity levels.

Innovation Solution

A process involving the reduction of methylene blue to a protonated stabilised leucomethylene blue complex using a metal-free carbocyclic or heterocyclic reducing agent, followed by recrystallization and subsequent oxidation back to methylene blue, effectively separates and removes Azure impurities and metal contaminants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional metal catalysts and metal equipment are used in methylene blue synthesis, then the synthesis process is efficient and cost-effective, but metal ion contamination occurs in the final product

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidmetal ion contamination
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention removes metal catalysts from the synthesis process entirely, replacing them with non-metallic alternatives. This extraction of the harmful element (metal) eliminates the source of contamination while maintaining synthesis efficiency through alternative catalytic or chemical methods that do not introduce metal ions into the final product.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces an intermediary purification step using activated charcoal or similar adsorbent materials. This intermediary substance captures and removes metal ion contaminants from the synthesis mixture, acting as a mediator between the metal-catalyzed synthesis process and the final metal-free product, thereby resolving the contradiction between using efficient metal catalysts and avoiding metal contamination.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Device complexity

If standard purification methods are used for methylene blue, then the process is simple, but Azure compound contaminants are not effectively removed due to structural similarity

Engineering Contradiction:
Improvepurification process simplicityVSAvoidpurity level
Core Design Contradiction:
Device complexityVSManufacturing precision

Solution Approach 1:

The invention changes the chemical parameters of the purification process by using selective reagents or conditions that exploit subtle differences between methylene blue and Azure compounds. For example, using specific pH conditions, oxidation-reduction potentials, or selective solvents that differentiate these structurally similar compounds, enabling effective separation while maintaining process simplicity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention employs a multi-stage purification approach where each stage targets specific types of contaminants. By creating a sequence of purification steps (copying the purification process multiple times with different methods), the system achieves high precision removal of Azure compounds while keeping the overall process manageable and systematically organized.

Inventive Principle:
Principle #26Copying

3Manufacturing precision

If multiple purification steps are added to remove Azure compounds and metal contaminants, then purity increases, but process complexity and cost increase

Engineering Contradiction:
Improvechemical purityVSAvoidpurification process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention merges multiple purification functions into integrated process steps. For example, combining filtration, adsorption, and washing operations into single consolidated steps, or using a multifunctional reagent that simultaneously removes multiple types of contaminants. This merging reduces the number of separate equipment units and operational steps while maintaining high purity levels, thereby resolving the contradiction between purity and complexity.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention implements a streamlined purification sequence that discards ineffective or redundant purification steps and recovers only the essential operations that provide maximum contaminant removal with minimum complexity. By identifying and eliminating unnecessary process steps while retaining the critical purification mechanisms, the system achieves high purity without proportionally increasing process complexity and cost.

Inventive Principle:
Principle #34Discarding and recovering

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly reduces metal ions and Azure compounds, achieving high chemical purity of methylene blue, meeting pharmaceutical standards with reduced contamination levels, and is applicable on an industrial scale in a cost-effective and simple manner.

Implementation Method 1

contacting the diaminophenothiazinium compound with a carbocyclic or heterocyclic reducing agent to form a protonated stabilised diaminophenothiazinium complex

Methodology Applied
Scientific EffectReduction: Reduction

Implementation Method 2

contacting the purified protonated stabilised diaminophenothiazinium complex with an oxidising agent to convert it back to the diaminophenothiazinium compound

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

purifying the protonated stabilised diaminophenothiazinium complex

Methodology Applied
Scientific EffectCrystallisation: Crystallisation

Data Source

PatentUS10160735B2Process for the purification of diaminophenothiazinium compounds
Publication Date: 2018.12.25 EUPHARMA
  • US10160735B2 patent drawing
  • US10160735B2 patent drawing
  • US10160735B2 patent drawing

AI summary

A process for the purification of diaminophenothiazinium compounds, and particularly of methylene blue, is described. The process provides for simple and effective purification by reduction of the post-synthesis or commercially available diaminophenothiazinium compound to form a reduced complex thereof. This can then be purified in a more straightforward manner than the original compound by, for example, recrystallization before being allowed to oxidize back to the diaminophenothiazinium compound.